Shailendra Lakhanpal MD
Hematology and Medical Oncology, Physician Partner at Alabama Oncology
Join to view full profile
100 Pilot Medical DriveSuite 175Birmingham, AL 35235
Phone+1 205-856-8488
Fax+1 205-856-8852
Dr. Lakhanpal is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Shailendra Lakhanpal is an oncologist based in Birmingham, AL, with specialized expertise in amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and multiple myeloma. He completed his fellowship in Hematology and Medical Oncology at the University of Texas Health Science Center San Antonio and has a medical degree from Delhi University College of Medical Sciences. His residency in Internal Medicine was completed at MedStar Health Georgetown University. Dr. Lakhanpal has contributed to several publications focusing on advanced breast cancer and tumor DNA, with his work being featured in journals such as The Oncologist and JTO Clinical and Research Reports.
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 1997 - 2000
MedStar Health Georgetown University (Baltimore)Residency, Internal Medicine, 1991 - 1994
Delhi University College of Medical SciencesClass of 1987
Certifications & Licensure
AL State Medical License 2001 - 2026
TX State Medical License 2001 - 2012
MD State Medical License 1994 - 1994
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Impact of Comorbidities on Clinical Outcomes and Quality of Life of Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2...Debu Tripathy, Joanne L Blum, Meghan S Karuturi, Steven McCune, Sobha Kurian
Cancer Medicine. 2026-04-01 - Enhancing the interpretation of real-world quality of life in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast...Gabrielle B Rocque, Joanne L Blum, Yan Ji, Timothy Pluard, John Migas
The Oncologist. 2025-10-01 - 9 citationsReal-World Validity of Tissue-Agnostic Circulating Tumor DNA Response Monitoring in Lung Cancers Treated With Chemotherapy, Immunotherapy, or Targeted Agents.Anne C Chiang, Russell W Madison, Zoe June Assaf, Alexander Fine, Yi Cao
JTO Clinical and Research Reports. 2025-09-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
